ERBB2 mutants displayed increased risks of polyp recurrence in Shanghai Renji center (P < 0.001), while no mutational factor was associated with polyp recurrence in patients from Chongqing TCM or Sichuan centers possibly due to the small sample size (Supplementary Figure S1). This evidence concerns the gene ERBB2 and polyp.